We hypothesize that the effect of CYP4F2 gene polymorphisms on the risk for lung cancer may be related to the metabolism of 20-HETE and then affect the growth of cancer cells by regulating the signal pathway of vascular endothelial growth factor. This evidence concerns the gene CYP4F2 and cancer.